ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
|Videos|September 12, 2016
Melanoma Survivors Encourage Others to Protect Their Skin
Author(s)Melanoma Foundation of New England
Advertisement
Melanoma is the second most common form of cancer for young people ages 15-29. It is a disease that affects a younger population. But the good news is: it’s preventable. By taking proper precautions and checking yourself monthly, you can protect yourself against melanoma.
Hear young survivors share their stories of survival.
Advertisement
Related to this article
Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.
Solid tumor history, cardiopulmonary symptom burden, and age-dependent chemo intensity predicted 30-day readmission or death after AML induction.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.
For Gynecologic Cancer Awareness Month, Amy Schultz, RN, details symptom identification, barrier mitigation, and caregiver support in oncology care.
At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.
Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma
2
FDA Advisory Panel Votes to Approve GRAIL Galleri MCED Screening Test
3
Outlining Tiered Self-Care Plans for Oncology Nurses
4
Oncology Nurse Shares Insights From Her Stage 4 Breast Cancer Journey
5